Jane M. Heffernan

5.5k citations

104 papers · 3.2k indexed · 2 hit papers · h-index 27

Modeling and Simulation top 0.1%
Public Health, Environmental and Occupational Health top 1%
Epidemiology top 5%
Infectious Diseases top 2%
Genetics top 5%

Co-authors: Lindi M. Wahl Robert J. SmithJian WuS.Karen Collinson Natasha S. Crowcroft Shelly BolotinYe LiYicang Zhou
Topics: COVID-19 epidemiological studies (50 papers)Mathematical and Theoretical Epidemiology and Ecology Models (29 papers)SARS-CoV-2 and COVID-19 Research (22 papers)
Cited by: Modeling and Simulation Virology Infectious Diseases
Journals: Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
Partner nations: Canada United States China

In The Last Decade

Jane M. Heffernan

102 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Perspectives on the basic reproductive ratio

2005 839 citations Jane M. Heffernan, Lindi M. Wahl et al. profile →
The basic reproduction number (R0) of measles: a systematic review

2017 385 citations Jane M. Heffernan et al. profile →

Peers

Countries citing papers authored by Jane M. Heffernan

Since Specialization

Citations

This map shows the geographic impact of Jane M. Heffernan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane M. Heffernan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane M. Heffernan more than expected).

Fields of papers citing papers by Jane M. Heffernan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane M. Heffernan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane M. Heffernan. The network helps show where Jane M. Heffernan may publish in the future.

Co-authorship network of co-authors of Jane M. Heffernan

This figure shows the co-authorship network connecting the top 25 collaborators of Jane M. Heffernan. A scholar is included among the top collaborators of Jane M. Heffernan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane M. Heffernan. Jane M. Heffernan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The impact of statistical adjustment for assay performance on inferences from SARS-CoV-2 serological surveillance studies 2025 ·American Journal of Epidemiology ·(unknown),(unknown),Sheila F. O’Brien,Carmen Charlton,Steven J. Drews,Jane M. Heffernan,Amber M. Smith,Yu Nakagama,Yasutoshi Kido,David L. Buckeridge,(unknown)	1
2	A pair formation model with recovery: Application to mpox 2023 ·Epidemics ·(unknown),(unknown),Jane M. Heffernan	7
3	Monkeypox: a review of epidemiological modelling studies and how modelling has led to mechanistic insight 2023 ·Epidemiology and Infection ·(unknown),Yang Yang,(unknown),Avneet Kaur,Zahid A Butt,Helen Chen,Svetlana Yanushkevich,Iain R. Moyles,Jane M. Heffernan,Chapin S. Korosec	25
4	Mitigating co-circulation of seasonal influenza and COVID-19 pandemic in the presence of vaccination: A mathematical modeling approach 2023 ·Frontiers in Public Health ·(unknown),(unknown),Nicola Luigi Bragazzi,(unknown),(unknown),Jane M. Heffernan,Jian Wu,(unknown)	8
5	Assessing transmission risks and control strategy for monkeypox as an emerging zoonosis in a metropolitan area 2022 ·Journal of Medical Virology ·Pei Yuan,Yi Tan,Liu Yang,(unknown),Nicholas H. Ogden,Jacques Bélair,Jane M. Heffernan,Julien Arino,James Watmough,Hélène Carabin,Huaiping Zhu	32
6	Could a New COVID-19 Mutant Strain Undermine Vaccination Efforts? A Mathematical Modelling Approach for Estimating the Spread of B.1.1.7 Using Ontario, Canada, as a Case Study 2021 ·Vaccines ·(unknown),Nicola Luigi Bragazzi,Jane M. Heffernan,Jude Dzevela Kong,(unknown)	10
7	Commentary on the use of the reproduction number R during the COVID-19 pandemic 2021 ·Statistical Methods in Medical Research ·Carolin Vegvari,Sam Abbott,Frank Ball,Ellen Brooks‐Pollock,Robert Challen,Benjamin Collyer,(unknown),Julia R. Gog,Katelyn M. Gostic,Jane M. Heffernan,T. Déirdre Hollingsworth,Valerie Isham,Eben Kenah,Denis Mollison,Jasmina Panovska‐Griffiths,Lorenzo Pellis,Michael C. Roberts,Gianpaolo Scalia Tomba,Robin N. Thompson,Pieter Trapman	25
8	Global sensitivity analysis of a single-cell HBV model for viral dynamics in the liver 2021 ·Infectious Disease Modelling ·(unknown),(unknown),Harvey Ho,Jane M. Heffernan	7
9	Impact of influenza vaccine-modified infectivity on attack rate, case fatality ratio and mortality 2020 ·Journal of Theoretical Biology ·Kyeongah Nah,(unknown),(unknown),Jane M. Heffernan,Jian Wu	5
10	Quantifying the shift in social contact patterns in response to non-pharmaceutical interventions 2020 ·SHILAP Revista de lepidopterología ·(unknown),Yanyu Xiao,Francesca Scarabel,Biao Tang,Nicola Luigi Bragazzi,Kyeongah Nah,Jane M. Heffernan,Ali Asgary,V. Kumar Murty,Nicholas H. Ogden,Jian Wu	15
11	De-Escalation by Reversing the Escalation with a Stronger Synergistic Package of Contact Tracing, Quarantine, Isolation and Personal Protection: Feasibility of Preventing a COVID-19 Rebound in Ontario, Canada, as a Case Study 2020 ·Biology ·Biao Tang,Francesca Scarabel,Nicola Luigi Bragazzi,(unknown),(unknown),Yanyu Xiao,Jane M. Heffernan,Ali Asgary,Nicholas H. Ogden,Jian Wu	39
12	De-escalation by Reversing the Escalation with a Stronger Synergistic Package of Contact Tracing, Quarantine, Isolation and Personal Protection: Feasibility of Preventing a COVID-19 Rebound in Ontario, Canada, as a Case Study 2020 ·SSRN Electronic Journal ·Biao Tang,Francesca Scarabel,Nicola Luigi Bragazzi,(unknown),(unknown),Yanyu Xiao,Jane M. Heffernan,Ali Asgary,Nicholas H. Ogden,Jian Wu	1
13	Interpretability and Class Imbalance in Prediction Models for Pain Volatility in Manage My Pain App Users: Analysis Using Feature Selection and Majority Voting Methods 2019 ·JMIR Medical Informatics ·Quazi Abidur Rahman,Tahir Janmohamed,Hance Clarke,Paul Ritvo,Jane M. Heffernan,Joel Katz	14
14	A threshold delay model of HIV infection of newborn infants through breastfeeding 2019 ·Infectious Disease Modelling ·Alexandra Teslya,(unknown),Jian Wu,Jane M. Heffernan	1
15	Defining and Predicting Pain Volatility in Users of the Manage My Pain App: Analysis Using Data Mining and Machine Learning Methods 2018 ·Journal of Medical Internet Research ·Quazi Abidur Rahman,Tahir Janmohamed,Meysam Pirbaglou,Hance Clarke,Paul Ritvo,Jane M. Heffernan,Joel Katz	30
16	Patterns of User Engagement With the Mobile App, Manage My Pain: Results of a Data Mining Investigation 2017 ·JMIR mhealth and uhealth ·Quazi Abidur Rahman,Tahir Janmohamed,Meysam Pirbaglou,Paul Ritvo,Jane M. Heffernan,Hance Clarke,Joel Katz	39
17	The time-interval between infections and viral hierarchies are determinants of viral interference following influenza virus infection in a ferret model 2016 ·European Journal of Immunology ·Karen Laurie,Teagan Guarnaccia,Louise Carolan,(unknown),Ada W. C. Yan,Malet Aban,Stephen Petrie,Pengxing Cao,Jane M. Heffernan,Jodie McVernon,Jennifer Mosse,Anne Kelso,James M. McCaw,Ian Barr	3
18	A delay-dependent model with HIV drug resistance during therapy 2014 ·Journal of Mathematical Analysis and Applications ·(unknown),Fred Brauer,Jian Wu,Jane M. Heffernan	22
19	Original Article: Highly conserved cross‐reactive CD4+ T‐cell HA‐epitopes of seasonal and the 2009 pandemic influenza viruses 2010 ·Influenza and Other Respiratory Viruses ·Venkata R. Duvvuri,Seyed M. Moghadas,Hongbin Guo,Bhargavi Duvvuri,Jane M. Heffernan,David N. Fisman,Gillian E. Wu,Jian Wu	34
20	The effects of genetic drift in experimental evolution 2002 ·Theoretical Population Biology ·Jane M. Heffernan,Lindi M. Wahl	29

About Jane M. Heffernan

Jane M. Heffernan is a scholar working on Modeling and Simulation, Virology and Infectious Diseases, having authored 104 papers that have together received 3.2k indexed citations. Recurring topics across this work include COVID-19 epidemiological studies (50 papers), Mathematical and Theoretical Epidemiology and Ecology Models (29 papers) and SARS-CoV-2 and COVID-19 Research (22 papers). The work is most often cited by research in Modeling and Simulation (1.5k citations), Virology (307 citations) and Infectious Diseases (882 citations). Jane M. Heffernan has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Lindi M. Wahl, Robert J. Smith, Jian Wu, S.Karen Collinson, Natasha S. Crowcroft, Shelly Bolotin, Ye Li, Yicang Zhou, Fiona Guerra and Shelley L. Deeks. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact